FDA CDER Small Business and Industry Assistance (SBIA) Chronicles

An FDA Self-Audit of Continuous Manufacturing for Drug Products

Continuous manufacturing (CM) technology has the potential to improve product quality and reliability, lower manufacturing costs, reduce waste, decrease inventory, and increase manufacturing flexibility and agility in response to product demand.